Quality, compliance and financial stability are top of mind in hospice merger and acquisitions (M&A) as this year comes to an end. Stakeholders are projecting a more frothy market in 2025, though regulatory concerns could sway buying decisions. Growing demand is among the constants driving investor interest in the hospice space, according to Tom Lillis, partner at the Kentucky-based firm Stoneridge Partners Strategic Consulting. But buyers have been relatively cautious and more selective when it comes to picking up hospice assets amid high interest rates, rising care delivery costs and regulatory scrutiny, Lillis stated.
Read the full article: ‘Signs of Life’: The 2025 Hospice M&A Outlook //
Source: https://hospicenews.com/2024/11/13/signs-of-life-the-2025-hospice-ma-outlook